Efficacy and safety of delafloxacin, ceftaroline, ceftobiprole, and tigecycline for the empiric treatment of acute bacterial skin and skin structure infections: A network meta-analysis of randomized controlled trials
Background: This review aimed to conduct an indirect comparison using a Bayesian network meta-analysis of randomized controlled trials (RCTs) to compare the efficacy and safety of delafloxacin versus other single antibiotic regimens for the empiric treatment of Acute Bacterial Skin and Skin Structur...
Main Authors: | Abdullah A. Alhifany, Nisrin Bifari, Yasser Alatawi, Saad U. Malik, Thamer A. Almangour, Ali F. Altebainawi, Thamir M. Alshammari, Amal F. Alotaibi, Ahmad J. Mahrous, Fahad S. Alshehri, Ejaz Cheema |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-03-01
|
Series: | Saudi Pharmaceutical Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1319016421002565 |
Similar Items
-
A randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infections
by: William O’Riordan, et al.
Published: (2015-01-01) -
Clinical outcomes of ceftobiprole in the treatment of acute bacterial skin and skin structure infections
by: Guang-Mao Lee, et al.
Published: (2021-03-01) -
Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin
by: Righi E, et al.
Published: (2018-04-01) -
Ceft-to-Ceft Study: Real-Life Experience with Ceftaroline and Ceftobiprole in Treatment of the Principal Infectious Syndromes in a Spanish Multicenter Hospital Cohort
by: Daniel Arnés García, et al.
Published: (2023-12-01) -
Update on the activity of delafloxacin against acute bacterial skin and skin-structure infection isolates from European hospitals (2014–2019)
by: Dee Shortridge, et al.
Published: (2020-12-01)